Search
Close this search box.
Search
Close this search box.

English

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery

Quantexa Introduces AI-Powered Workload for Microsoft Fabric to Transform Data Quality and Usability Across the Enterprise

• The Quantexa Unify Workload for Microsoft Fabric gives users industry-leading entity resolution capabilities to perform highly accurate data-matching and relationship-discovery at scale. • Organizations can enhance data quality, eliminate silos, lower costs and address challenges linked to getting data ready for AI, facilitating better and faster decision-making. LONDON

Quantexa Introduces AI-Powered Workload for Microsoft Fabric to Transform Data Quality and Usability Across the Enterprise

• The Quantexa Unify Workload for Microsoft Fabric gives users industry-leading entity resolution capabilities to perform highly accurate data-matching and relationship-discovery at scale. • Organizations can enhance data quality, eliminate silos, lower costs and address challenges linked to getting data ready for AI, facilitating better and faster decision-making. LONDON

Tū Ātea and Mavenir Partner to Pioneer Future of Networks Using Māori Spectrum Assets

Tū Ātea and Mavenir Partner to Pioneer Future of Networks Using Māori Spectrum Assets RICHARDSON, Texas, Nov. 14, 2024 (GLOBE NEWSWIRE) — Mavenir, the cloud-native network infrastructure provider building the future of networks, today announces a transformative partnership with Tū Ātea Limited, an Indigenous Aotearoa/New Zealand company dedicated to advancing